Antigenicity of Leishmania-Activated C-Kinase Antigen (LACK) in Human Peripheral Blood Mononuclear Cells, and Protective Effect of Prime-Boost Vaccination With pCI-neo-LACK Plus Attenuated LACK-Expressing Vaccinia Viruses in Hamsters-Reference-Cited by-同舟云学术

Antigenicity of Leishmania-Activated C-Kinase Antigen (LACK) in Human Peripheral Blood Mononuclear Cells, and Protective Effect of Prime-Boost Vaccination With pCI-neo-LACK Plus Attenuated LACK-Expressing Vaccinia Viruses in Hamsters

Published:2018-04-23 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Fernández Laura,Carrillo Eugenia,Sánchez-Sampedro Lucas,Sánchez Carmen,Ibarra-Meneses Ana Victoria,Jimenez Mͣ Angeles,Almeida Valter dos Anjos,Esteban Mariano,Moreno Javier

Funder

Ministerio de Economía y Competitividad

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference35 articles.

1. Social and economic burden of human leishmaniasis;Okwor;Am J Trop Med Hyg,2016

2. From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE;Coler;Clin Transl Immunol,2015

3. Vaccines to prevent leishmaniasis;Kumar;Clin Transl Immunol,2014

4. Status of vaccine research and development of vaccines for leishmaniasis;Gillespie;Vaccine,2016

5. Case study for a vaccine against leishmaniasis;Alvar;Vaccine,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppressants alter the immune response associated with Glucantime® treatment for Leishmania infantum infection in a mouse model;Frontiers in Immunology;2023-12-01

2. A non-replicative antibiotic resistance-free DNA vaccine delivered by the intranasal route protects against canine leishmaniasis;Frontiers in Immunology;2023-09-18

3. Touching Base with Some Mediterranean Diseases of Interest from Paradigmatic Cases at the “Magna Graecia” University Unit of Infectious Diseases: A Didascalic Review;Diagnostics;2023-09-01

4. In silico designing of a novel polyvalent multi-subunit peptide vaccine leveraging cross-immunity against human visceral and cutaneous leishmaniasis: an immunoinformatics-based approach;Journal of Molecular Modeling;2023-03-16

5. Visceral and Tegumentary Leishmaniasis;Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges;2023